Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
2014 · New England Journal of Medicine · 3,004 citations
https://doi.org/10.1056/nejmoa1405095
T
Tomasz M. Beer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
791
Papers
37.6K
Citations
81
h-index
279
i10-index
Tomasz M. Beer is an academic researcher from Exact Sciences (United States). The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer, Lipids, and Metabolism & Prostate Cancer Diagnosis and Treatment. The author has an h-index of 81, co-authored 673 publications.
ORCID: 0000-0001-5600-9993Papers by this author
worksLutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 · New England Journal of Medicine · 2,316 citations
https://doi.org/10.1056/nejmoa2107322
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
2018 · Cell · 724 citations
https://doi.org/10.1016/j.cell.2018.06.039
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study
2023 · The Lancet · 303 citations
https://doi.org/10.1016/s0140-6736(23)01700-2
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance
2020 · Proceedings of the National Academy of Sciences · 167 citations
https://doi.org/10.1073/pnas.1922207117
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
2023 · European Journal of Cancer · 148 citations
https://doi.org/10.1016/j.ejca.2023.02.018
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat